The article Cybin Reports Q3 Financial Results and Business Highlights was originally published on Microdose. Cybin has released its Q3 financial results...
The company received approval in the Netherlands to start dosing humans with one of its compounds. The post Cybin Maintains Steady Runway, Finds Approval...
The 5 categories in the cannabis sector perform quite differently from each other on a weekly basis and below is a summary of how each category ...
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but many of them could possibly bounce back with major returns – dare...
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now...
Cybin (NEO: CYBN | NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has scheduled a virtual R&D...
The article News You Might Have Missed: Jan 23rd, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Investing in psychedelic companies has become increasingly popular in the past few years. Here at Psychedelic Invest, our goal is to connect you to the...
Investing in psychedelic companies has become increasingly popular in the past few years. Here at Psychedelic Invest, our goal is to connect you to the...
The article Cybin Announces Promising Results From Study Measuring Psychedelic Effects on the Brain was originally published on Microdose. Cybin Announces...